BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 20800380)

  • 1. Primary analysis of a phase II randomized trial Radiation Therapy Oncology Group (RTOG) 0212: impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited-disease small-cell lung cancer.
    Wolfson AH; Bae K; Komaki R; Meyers C; Movsas B; Le Pechoux C; Werner-Wasik M; Videtic GM; Garces YI; Choy H
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):77-84. PubMed ID: 20800380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized Phase III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small-Cell Lung Cancer (PREMER): A GICOR-GOECP-SEOR Study.
    Rodríguez de Dios N; Couñago F; Murcia-Mejía M; Rico-Oses M; Calvo-Crespo P; Samper P; Vallejo C; Luna J; Trueba I; Sotoca A; Cigarral C; Farré N; Manero RM; Durán X; Gispert JD; Sánchez-Benavides G; Rognoni T; Torrente M; Capellades J; Jiménez M; Cabada T; Blanco M; Alonso A; Martínez-San Millán J; Escribano J; González B; López-Guerra JL
    J Clin Oncol; 2021 Oct; 39(28):3118-3127. PubMed ID: 34379442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trial.
    Le Péchoux C; Dunant A; Senan S; Wolfson A; Quoix E; Faivre-Finn C; Ciuleanu T; Arriagada R; Jones R; Wanders R; Lerouge D; Laplanche A;
    Lancet Oncol; 2009 May; 10(5):467-74. PubMed ID: 19386548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective Study of Hippocampal-Sparing Prophylactic Cranial Irradiation in Limited-Stage Small Cell Lung Cancer.
    Redmond KJ; Hales RK; Anderson-Keightly H; Zhou XC; Kummerlowe M; Sair HI; Duhon M; Kleinberg L; Rosner GL; Vannorsdall T
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):603-611. PubMed ID: 28581401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01).
    Le Péchoux C; Laplanche A; Faivre-Finn C; Ciuleanu T; Wanders R; Lerouge D; Keus R; Hatton M; Videtic GM; Senan S; Wolfson A; Jones R; Arriagada R; Quoix E; Dunant A;
    Ann Oncol; 2011 May; 22(5):1154-1163. PubMed ID: 21139020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized phase II trial comparing twice daily hyperfractionated with once daily hypofractionated thoracic radiotherapy in limited disease small cell lung cancer.
    Grønberg BH; Halvorsen TO; Fløtten Ø; Brustugun OT; Brunsvig PF; Aasebø U; Bremnes RM; Tollåli T; Hornslien K; Aksnessæther BY; Liaaen ED; Sundstrøm S;
    Acta Oncol; 2016 May; 55(5):591-7. PubMed ID: 26494411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic cranial irradiation versus observation in patients with extensive-disease small-cell lung cancer: a multicentre, randomised, open-label, phase 3 trial.
    Takahashi T; Yamanaka T; Seto T; Harada H; Nokihara H; Saka H; Nishio M; Kaneda H; Takayama K; Ishimoto O; Takeda K; Yoshioka H; Tachihara M; Sakai H; Goto K; Yamamoto N
    Lancet Oncol; 2017 May; 18(5):663-671. PubMed ID: 28343976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized Phase II Study Comparing Prophylactic Cranial Irradiation Alone to Prophylactic Cranial Irradiation and Consolidative Extracranial Irradiation for Extensive-Disease Small Cell Lung Cancer (ED SCLC): NRG Oncology RTOG 0937.
    Gore EM; Hu C; Sun AY; Grimm DF; Ramalingam SS; Dunlap NE; Higgins KA; Werner-Wasik M; Allen AM; Iyengar P; Videtic GMM; Hales RK; McGarry RC; Urbanic JJ; Pu AT; Johnstone CA; Stieber VW; Paulus R; Bradley JD
    J Thorac Oncol; 2017 Oct; 12(10):1561-1570. PubMed ID: 28648948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twice-daily prophylactic cranial irradiation for patients with limited disease small-cell lung cancer with complete response to chemotherapy and consolidative radiotherapy: report of a single institutional phase II trial.
    Wolfson AH; Bains Y; Lu J; Etuk B; Sridhar K; Raub W; Markoe A
    Am J Clin Oncol; 2001 Jun; 24(3):290-5. PubMed ID: 11404503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial.
    Grønberg BH; Killingberg KT; Fløtten Ø; Brustugun OT; Hornslien K; Madebo T; Langer SW; Schytte T; Nyman J; Risum S; Tsakonas G; Engleson J; Halvorsen TO
    Lancet Oncol; 2021 Mar; 22(3):321-331. PubMed ID: 33662285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective evaluation of whole brain volume loss and neurocognitive decline following hippocampal-sparing prophylactic cranial irradiation for limited-stage small-cell lung cancer.
    Gui C; Chintalapati N; Hales RK; Voong KR; Sair HI; Grimm J; Duhon M; Kleinberg LR; Vannorsdall TD; Redmond KJ
    J Neurooncol; 2019 Sep; 144(2):351-358. PubMed ID: 31302830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re-evaluation of prophylactic cranial irradiation in limited-stage small cell lung cancer: a propensity score matched analysis.
    Inoue Y; Tsujino K; Sulaiman NS; Marudai M; Kajihara A; Miyazaki S; Sekii S; Uezono H; Ota Y; Soejima T
    J Radiat Res; 2021 Sep; 62(5):877-883. PubMed ID: 34230962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practice guideline on prophylactic cranial irradiation in small-cell lung cancer.
    Kotalik J; Yu E; Markman BR; Evans WK;
    Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):309-16. PubMed ID: 11380216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic Cranial Irradiation for Limited-Stage Small-Cell Lung Cancer Patients: Secondary Findings From the Prospective Randomized Phase 3 CONVERT Trial.
    Levy A; Le Péchoux C; Mistry H; Martel-Lafay I; Bezjak A; Lerouge D; Padovani L; Taylor P; Faivre-Finn C
    J Thorac Oncol; 2019 Feb; 14(2):294-297. PubMed ID: 30292850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decline in tested and self-reported cognitive functioning after prophylactic cranial irradiation for lung cancer: pooled secondary analysis of Radiation Therapy Oncology Group randomized trials 0212 and 0214.
    Gondi V; Paulus R; Bruner DW; Meyers CA; Gore EM; Wolfson A; Werner-Wasik M; Sun AY; Choy H; Movsas B
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):656-64. PubMed ID: 23597420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rates of Overall Survival and Intracranial Control in the Magnetic Resonance Imaging Era for Patients With Limited-Stage Small Cell Lung Cancer With and Without Prophylactic Cranial Irradiation.
    Pezzi TA; Fang P; Gjyshi O; Feng L; Liu S; Komaki R; Lin SH
    JAMA Netw Open; 2020 Apr; 3(4):e201929. PubMed ID: 32236532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal Brain Changes Associated with Prophylactic Cranial Irradiation in Lung Cancer.
    Simó M; Vaquero L; Ripollés P; Gurtubay-Antolin A; Jové J; Navarro A; Cardenal F; Bruna J; Rodríguez-Fornells A
    J Thorac Oncol; 2016 Apr; 11(4):475-86. PubMed ID: 26804637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is There a Role for Hypofractionated Thoracic Radiation Therapy in Limited-Stage Small Cell Lung Cancer? A Propensity Score Matched Analysis.
    Zayed S; Chen H; Ali E; Rodrigues GB; Warner A; Palma DA; Louie AV
    Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):575-586. PubMed ID: 32544575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-reported health-related quality of life from a randomized phase II trial comparing standard-dose with high-dose twice daily thoracic radiotherapy in limited stage small-cell lung cancer.
    Killingberg KT; Halvorsen TO; Fløtten Ø; Brustugun OT; Langer SW; Nyman J; Hornslien K; Madebo T; Schytte T; Risum S; Tsakonas G; Engleson J; Grønberg BH
    Lung Cancer; 2022 Apr; 166():49-57. PubMed ID: 35183991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study protocol: watchful observation of patients with limited small cell lung cancer instead of the PCI-prospective, multi-center one-arm study.
    Nawrocki S; Sugajska A
    BMC Cancer; 2020 Mar; 20(1):231. PubMed ID: 32188425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.